JusticeItaly Official institution

Italy withdraws marketing permission for Recotuss Sedativo medicine

Italy's medicines agency AIFA has published a notice that the marketing permission for the cough medicine Recotuss Sedativo is being withdrawn. The company holding the permission voluntarily gave it up, so the product's legal authorization to be sold ends. The notice was published on 7 November 2026 under reference 26A05796.

This summary was generated by AI; the official source prevails.

What does it mean?

Recotuss Sedativo is a medicine sold in Italy, and it can no longer be legally sold once this withdrawal takes effect. The company that held the permission asked to give it up, so the regulator is cancelling it. If you use this product, check with your pharmacist for alternatives.

Who is affected?

Patients who use Recotuss Sedativo and pharmacies that stock it.

What changes?

Until now, Recotuss Sedativo was authorized for sale in Italy; now that authorization is being revoked at the company's own request.